Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2023 Earnings Call Transcript

Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2023 Earnings Call Transcript August 2, 2023

Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $-2.68 EPS, expectations were $2.58.

Operator: Good morning, ladies and gentlemen. My name is Glen. I’ll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines Second Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any...